In continuation of our intimation for outcome of the meeting dated 15/04/2025, we are submitting a draft letter of offer upto Rs. 725 lakhs approved by the Board of directors of the company ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Tejnaksh Healthcare Ltd's Board of Directors, at a meeting held on April 15, 2025, approved the Draft Letter of Offer for a proposed Rights Issue of equity shares aggregating up to Rs. 725 lakhs. The equity shares will have a face value of Rs. 5 each, and the issue will be offered to existing eligible equity shareholders in a ratio yet to be finalized. The issue price, premium, record date, and entitlement ratio are still to be determined and will be disclosed later. The company plans to file the Draft Letter of Offer with BSE for approval. Additionally, the proposal to shift the registered office within Mumbai has been put on hold, and the appointment of intermediaries for the rights issue will be discussed later.
This is a fund-raising move that may dilute existing shareholders' holdings unless they participate in full. Since the issue size is relatively small (Rs. 725 lakhs) and the issue price/premium has not been disclosed yet, shareholders should wait for further details on pricing, record date, and entitlement ratio before assessing the actual impact.